Universal Diagnostics Olympus
1 known investors
Universal DX develops blood-based tests to detect cancer at early stages using multi-omics, computational biology, and machine learning to read cancer signals in blood. Its first test, Signal-C, detects colorectal cancer and is intended for distribution through the Quest Diagnostics network in the U.S. following FDA approval.
AI & Machine LearningBiotechDigital Health
Investors · 1
Frequently asked questions
- What does Universal Diagnostics Olympus do?
- Universal DX develops blood-based tests to detect cancer at early stages using multi-omics, computational biology, and machine learning to read cancer signals in blood. Its first test, Signal-C, detects colorectal cancer and is intended for distribution through the Quest Diagnostics network in the U.S. following FDA approval.
- Who are Universal Diagnostics Olympus's investors?
- Universal Diagnostics Olympus's investors include Cerity Partners Ventures.